Search results
Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while advancing a healthier, more sustainable and ...
- Pipeline
Breaking New Ground With Science. With a strong focus on...
- News Releases
EISAI and Biogen Inc. Announce U.S. FDA Grants Breakthrough...
- Contact Us
Alzheimer’s Support Alzheimer’s Support Services...
- Multiple Sclerosis (MS)
Multiple sclerosis (MS) is a complex, heterogeneous, chronic...
- Investor Relations
Founded in 1978, Biogen is a leading global biotechnology...
- Responsibility
For Biogen, that includes bolstering our commitment to...
- Pipeline
Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while advancing a healthier, more sustainable and ...
History. Biogen was founded in 1978 in Geneva as Biotechnology Geneva by several prominent biologists, including Kenneth Murray from the University of Edinburgh, Phillip Allen Sharp from the Massachusetts Institute of Technology, Walter Gilbert from Harvard University (Gilbert served as CEO during the start-up phase of Biogen), Heinz Schaller from the University of Heidelberg, and Charles ...
- 1978; 45 years ago
- Cambridge, Massachusetts, U.S.
- 8,725 (2022)
- US$10.17 billion (2022)
People also ask
What does Biogen do?
Who is Biogen company?
Who is Biogen & why should you care?
Is Biogen a stock?
Apr 25, 2023 · F.D.A. Approves Drug for Rare Form of A.L.S. The drug, which will be sold as Qalsody by the pharmaceutical company Biogen, targets a genetic cause of a devastating neurological illness. The ...
Sep 29, 2023 · About Biogen Founded in 1978, Biogen is a leading global biotechnology company that has pioneered multiple breakthrough innovations including a broad portfolio of medicines to treat multiple sclerosis, the first approved treatment for spinal muscular atrophy, and two co-developed treatments to address a defining pathology of Alzheimer’s disease.
